192 related articles for article (PubMed ID: 30618026)
1. No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age.
Li L; Wei L; Xu ZG; Ma L
Am J Clin Dermatol; 2019 Apr; 20(2):289-293. PubMed ID: 30618026
[TBL] [Abstract][Full Text] [Related]
2. Deep coma in a child treated with propranolol for infantile hemangioma.
Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
Olsen GM; Hansen LM; Stefanko NS; Mathes E; Puttgen KB; Tollefson MM; Lauren C; Mancini AJ; McCuaig CC; Frieden IJ; Adams D; Baselga E; Chamlin S; Gupta D; Frommelt P; Garzon MC; Horii K; Klajn J; Maheshwari M; Newell B; Nguyen HL; Nopper A; Powell J; Siegel DH; Drolet BA
JAMA Dermatol; 2020 Feb; 156(2):186-190. PubMed ID: 31825455
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of propranolol for cutaneous hemangiomas in premature children.
Brazzelli V; Giorgini C; Barruscotti S; Codazzi CA; Mannarino S; Tzialla C; Stronati M; Marseglia GL; Borroni G
G Ital Dermatol Venereol; 2016 Oct; 151(5):485-91. PubMed ID: 25692776
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
9. Safety assessment of propranolol for infantile hemangioma: a study in an Asian population.
Yu L; Wei L; Xu Z; Zhang B; Han X; Sun Y; Liu Y; Wang C; Qiu L; Xiu B; He R; Li L; Ma L
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):237-242. PubMed ID: 34918994
[TBL] [Abstract][Full Text] [Related]
10. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
12. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
13. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
15. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population.
Fu R; Zou Y; Wu Z; Jin P; Cheng J; Bai H; Huang M; Huan X; Yuan H
Sci Rep; 2023 Apr; 13(1):5956. PubMed ID: 37046020
[TBL] [Abstract][Full Text] [Related]
16. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
[TBL] [Abstract][Full Text] [Related]
17. Oral propranolol for infantile haemangioma may be associated with transient gross motor delay.
Mahon C; Heron G; Perkins D; Drage A; Wargon O
Br J Dermatol; 2018 Jun; 178(6):1443-1444. PubMed ID: 29330846
[No Abstract] [Full Text] [Related]
18. Propranolol treatment for hemangioma of infancy: risks and recommendations.
Lawley LP; Siegfried E; Todd JL
Pediatr Dermatol; 2009; 26(5):610-4. PubMed ID: 19840322
[TBL] [Abstract][Full Text] [Related]
19. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
